1 Vaccine Adjuvants Market Overview 1.1 Vaccine Adjuvants Product Scope 1.2 Vaccine Adjuvants Segment by Type 1.2.1 Global Vaccine Adjuvants Sales by Type (2020-2026) 1.2.2 Oral 1.2.3 Subcutaneous 1.2.4 Intramuscular 1.2.5 Others 1.3 Vaccine Adjuvants Segment by Application 1.3.1 Global Vaccine Adjuvants Sales Comparison by Application (2020-2026) 1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) 1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications) 1.4 Vaccine Adjuvants Market Estimates and Forecasts (2015-2026) 1.4.1 Global Vaccine Adjuvants Sales Growth Rate (2015-2026) 1.4.2 Global Vaccine Adjuvants Revenue and Growth Rate (2015-2026) 1.4.3 Global Vaccine Adjuvants Price Trends (2015-2026) 2 Vaccine Adjuvants Estimate and Forecast by Region 2.1 Global Vaccine Adjuvants Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Vaccine Adjuvants Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Vaccine Adjuvants Sales Market Share by Region (2015-2020) 2.2.2 Global Vaccine Adjuvants Revenue Market Share by Region (2015-2020) 2.3 Global Vaccine Adjuvants Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Vaccine Adjuvants Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Vaccine Adjuvants Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Vaccine Adjuvants Estimates and Projections (2015-2026) 2.4.2 Europe Vaccine Adjuvants Estimates and Projections (2015-2026) 2.4.3 China Vaccine Adjuvants Estimates and Projections (2015-2026) 2.4.4 Japan Vaccine Adjuvants Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Vaccine Adjuvants Estimates and Projections (2015-2026) 2.4.6 India Vaccine Adjuvants Estimates and Projections (2015-2026) 3 Global Vaccine Adjuvants Competition Landscape by Players 3.1 Global Top Vaccine Adjuvants Players by Sales (2015-2020) 3.2 Global Top Vaccine Adjuvants Players by Revenue (2015-2020) 3.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Adjuvants as of 2019) 3.4 Global Vaccine Adjuvants Average Price by Company (2015-2020) 3.5 Manufacturers Vaccine Adjuvants Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Vaccine Adjuvants Players (Opinion Leaders) 4 Global Vaccine Adjuvants Market Size by Type 4.1 Global Vaccine Adjuvants Historic Market Review by Type (2015-2020) 4.1.1 Global Vaccine Adjuvants Sales Market Share by Type (2015-2020) 4.1.2 Global Vaccine Adjuvants Revenue Market Share by Type (2015-2020) 4.1.3 Global Vaccine Adjuvants Price by Type (2015-2020) 4.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Vaccine Adjuvants Sales Forecast by Type (2021-2026) 4.2.2 Global Vaccine Adjuvants Revenue Forecast by Type (2021-2026) 4.2.3 Global Vaccine Adjuvants Price Forecast by Type (2021-2026) 5 Global Vaccine Adjuvants Market Size by Application 5.1 Global Vaccine Adjuvants Historic Market Review by Application (2015-2020) 5.1.1 Global Vaccine Adjuvants Sales Market Share by Application (2015-2020) 5.1.2 Global Vaccine Adjuvants Revenue Market Share by Application (2015-2020) 5.1.3 Global Vaccine Adjuvants Price by Application (2015-2020) 5.2 Global Vaccine Adjuvants Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Vaccine Adjuvants Sales Forecast by Application (2021-2026) 5.2.2 Global Vaccine Adjuvants Revenue Forecast by Application (2021-2026) 5.2.3 Global Vaccine Adjuvants Price Forecast by Application (2021-2026) 6 United States Vaccine Adjuvants Market Facts & Figures 6.1 United States Vaccine Adjuvants Sales Market Share by Company (2015-2020) 6.2 United States Vaccine Adjuvants Sales Market Share by Type (2015-2020) 6.3 United States Vaccine Adjuvants Sales Market Share by Application (2015-2020) 7 Europe Vaccine Adjuvants Market Facts & Figures 7.1 Europe Vaccine Adjuvants Sales Market Share by Company (2015-2020) 7.2 Europe Vaccine Adjuvants Sales Market Share by Type (2015-2020) 7.3 Europe Vaccine Adjuvants Sales Market Share by Application (2015-2020) 8 China Vaccine Adjuvants Market Facts & Figures 8.1 China Vaccine Adjuvants Sales Market Share by Company (2015-2020) 8.2 China Vaccine Adjuvants Sales Market Share by Type (2015-2020) 8.3 China Vaccine Adjuvants Sales Market Share by Application (2015-2020) 9 Japan Vaccine Adjuvants Market Facts & Figures 9.1 Japan Vaccine Adjuvants Sales Market Share by Company (3015-3030) 9.2 Japan Vaccine Adjuvants Sales Market Share by Type (2015-2020) 9.3 Japan Vaccine Adjuvants Sales Market Share by Application (2015-2020) 10 Southeast Asia Vaccine Adjuvants Market Facts & Figures 10.1 Southeast Asia Vaccine Adjuvants Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Vaccine Adjuvants Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Vaccine Adjuvants Sales Market Share by Application (2015-2020) 11 India Vaccine Adjuvants Market Facts & Figures 11.1 India Vaccine Adjuvants Sales Market Share by Company (2015-2020) 11.2 India Vaccine Adjuvants Sales Market Share by Type (2015-2020) 11.3 India Vaccine Adjuvants Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Vaccine Adjuvants Business 12.1 SEPPIC 12.1.1 SEPPIC Corporation Information 12.1.2 SEPPIC Business Overview 12.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.1.4 SEPPIC Vaccine Adjuvants Products Offered 12.1.5 SEPPIC Recent Development 12.2 SDA BIO 12.2.1 SDA BIO Corporation Information 12.2.2 SDA BIO Business Overview 12.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.2.4 SDA BIO Vaccine Adjuvants Products Offered 12.2.5 SDA BIO Recent Development 12.3 Croda International Plc 12.3.1 Croda International Plc Corporation Information 12.3.2 Croda International Plc Business Overview 12.3.3 Croda International Plc Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Croda International Plc Vaccine Adjuvants Products Offered 12.3.5 Croda International Plc Recent Development 12.4 SPI Pharma 12.4.1 SPI Pharma Corporation Information 12.4.2 SPI Pharma Business Overview 12.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.4.4 SPI Pharma Vaccine Adjuvants Products Offered 12.4.5 SPI Pharma Recent Development 12.5 Phibro Animal Health Corporation 12.5.1 Phibro Animal Health Corporation Corporation Information 12.5.2 Phibro Animal Health Corporation Business Overview 12.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Phibro Animal Health Corporation Vaccine Adjuvants Products Offered 12.5.5 Phibro Animal Health Corporation Recent Development 12.6 Tj Kaiwei 12.6.1 Tj Kaiwei Corporation Information 12.6.2 Tj Kaiwei Business Overview 12.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Tj Kaiwei Vaccine Adjuvants Products Offered 12.6.5 Tj Kaiwei Recent Development 12.7 Novavax 12.7.1 Novavax Corporation Information 12.7.2 Novavax Business Overview 12.7.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Novavax Vaccine Adjuvants Products Offered 12.7.5 Novavax Recent Development 12.8 Zhuoyue 12.8.1 Zhuoyue Corporation Information 12.8.2 Zhuoyue Business Overview 12.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Zhuoyue Vaccine Adjuvants Products Offered 12.8.5 Zhuoyue Recent Development 12.9 Aphios 12.9.1 Aphios Corporation Information 12.9.2 Aphios Business Overview 12.9.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Aphios Vaccine Adjuvants Products Offered 12.9.5 Aphios Recent Development 12.10 GSK 12.10.1 GSK Corporation Information 12.10.2 GSK Business Overview 12.10.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.10.4 GSK Vaccine Adjuvants Products Offered 12.10.5 GSK Recent Development 12.11 CSL Limited 12.11.1 CSL Limited Corporation Information 12.11.2 CSL Limited Business Overview 12.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.11.4 CSL Limited Vaccine Adjuvants Products Offered 12.11.5 CSL Limited Recent Development 12.12 Brenntag Biosector 12.12.1 Brenntag Biosector Corporation Information 12.12.2 Brenntag Biosector Business Overview 12.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Brenntag Biosector Vaccine Adjuvants Products Offered 12.12.5 Brenntag Biosector Recent Development 12.13 SEPPIC 12.13.1 SEPPIC Corporation Information 12.13.2 SEPPIC Business Overview 12.13.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.13.4 SEPPIC Vaccine Adjuvants Products Offered 12.13.5 SEPPIC Recent Development 12.14 SPI Pharma 12.14.1 SPI Pharma Corporation Information 12.14.2 SPI Pharma Business Overview 12.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.14.4 SPI Pharma Vaccine Adjuvants Products Offered 12.14.5 SPI Pharma Recent Development 12.15 Novavax 12.15.1 Novavax Corporation Information 12.15.2 Novavax Business Overview 12.15.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Novavax Vaccine Adjuvants Products Offered 12.15.5 Novavax Recent Development 12.16 Avanti Polar Lipids 12.16.1 Avanti Polar Lipids Corporation Information 12.16.2 Avanti Polar Lipids Business Overview 12.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.16.4 Avanti Polar Lipids Vaccine Adjuvants Products Offered 12.16.5 Avanti Polar Lipids Recent Development 12.17 Aphios 12.17.1 Aphios Corporation Information 12.17.2 Aphios Business Overview 12.17.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2015-2020) 12.17.4 Aphios Vaccine Adjuvants Products Offered 12.17.5 Aphios Recent Development 13 Vaccine Adjuvants Manufacturing Cost Analysis 13.1 Vaccine Adjuvants Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Vaccine Adjuvants 13.4 Vaccine Adjuvants Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Vaccine Adjuvants Distributors List 14.3 Vaccine Adjuvants Customers 15 Market Dynamics 15.1 Vaccine Adjuvants Market Trends 15.2 Vaccine Adjuvants Opportunities and Drivers 15.3 Vaccine Adjuvants Market Challenges 15.4 Vaccine Adjuvants Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Vaccine Adjuvants Sales (Kg) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Vaccine Adjuvants Sales (Kg) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Vaccine Adjuvants Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Vaccine Adjuvants Sales (Kg) by Region (2015-2020) Table 5. Global Vaccine Adjuvants Sales Market Share by Region (2015-2020) Table 6. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Vaccine Adjuvants Revenue Share by Region (2015-2020) Table 8. Global Vaccine Adjuvants Sales (Kg) Forecast by Region (2021-2026) Table 9. Global Vaccine Adjuvants Sales Market Share Forecast by Region (2021-2026) Table 10. Global Vaccine Adjuvants Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Vaccine Adjuvants Revenue Share Forecast by Region (2021-2026) Table 12. Global Vaccine Adjuvants (Kg) of Key Companies (2015-2020) Table 13. Global Vaccine Adjuvants Sales Share by Company (2015-2020) Table 14. Global Vaccine Adjuvants Revenue (US$ Million) by Company (2015-2020) Table 15. Global Vaccine Adjuvants Revenue Share by Company (2015-2020) Table 16. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Adjuvants as of 2019) Table 17. Global Vaccine Adjuvants Average Price (USD/Kg) of Key Company (2015-2020) Table 18. Manufacturers Vaccine Adjuvants Manufacturing Sites and Area Served Table 19. Manufacturers Vaccine Adjuvants Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Vaccine Adjuvants Players Table 22. Global Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 23. Global Vaccine Adjuvants Sales Share by Type (2015-2020) Table 24. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Vaccine Adjuvants Price (Kg) by Type (2015-2020) Table 26. Global Vaccine Adjuvants Sales Share by Type (2021-2026) Table 27. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Vaccine Adjuvants Revenue Share by Type (2021-2026) Table 29. Global Vaccine Adjuvants Price (Kg) by Type (2021-2026) Table 30. Global Vaccine Adjuvants Sales (Kg) by Application (2015-2020) Table 31. Global Vaccine Adjuvants Sales Share by Application (2015-2020) Table 32. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Vaccine Adjuvants Price (Kg) by Application (2015-2020) Table 34. Global Vaccine Adjuvants Sales (Kg) by Application (2021-2026) Table 35. Global Vaccine Adjuvants Sales Share by Application (2021-2026) Table 36. Global Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Vaccine Adjuvants Revenue Share by Application (2021-2026) Table 38. Global Vaccine Adjuvants Price (Kg) by Application (2021-2026) Table 39. United States Vaccine Adjuvants Sales (Kg) by Company (2015-2020) Table 40. United States Vaccine Adjuvants Sales Market Share by Company (2015-2020) Table 41. United States Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 42. United States Vaccine Adjuvants Sales Market Share by Type (2015-2020) Table 43. United States Vaccine Adjuvants Sales (Kg) by Application (2015-2020) Table 44. United States Vaccine Adjuvants Sales Market Share by Application (2015-2020) Table 45. Europe Vaccine Adjuvants Sales (Kg) by Company (2015-2020) Table 46. Europe Vaccine Adjuvants Sales Market Share by Company (2015-2020) Table 47. Europe Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 48. Europe Vaccine Adjuvants Sales Market Share by Type (2015-2020) Table 49. Europe Vaccine Adjuvants Sales (Kg) by Application (2015-2020) Table 50. Europe Vaccine Adjuvants Sales Market Share by Type (2015-2020) Table 51. China Vaccine Adjuvants Sales (Kg) by Company (2015-2020) Table 52. China Vaccine Adjuvants Sales Market Share by Company (2015-2020) Table 53. China Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 54. China Vaccine Adjuvants Sales Market Share by Type (2015-2020) Table 55. China Vaccine Adjuvants Sales (Kg) by Application (2015-2020) Table 56. China Vaccine Adjuvants Sales Market Share by Application (2015-2020) Table 57. Japan Vaccine Adjuvants Sales (Kg) by Company (2015-2020) Table 58. Japan Vaccine Adjuvants Sales Market Share by Company (2015-2020) Table 59. Japan Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 60. Japan Vaccine Adjuvants Sales Market Share by Type (2015-2020) Table 61. Japan Vaccine Adjuvants Sales (Kg) by Application (2015-2020) Table 62. Japan Vaccine Adjuvants Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Vaccine Adjuvants Sales (Kg) by Company (2015-2020) Table 64. Southeast Asia Vaccine Adjuvants Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 66. Southeast Asia Vaccine Adjuvants Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 68. Southeast Asia Vaccine Adjuvants Sales Market Share by Application (2015-2020) Table 69. India Vaccine Adjuvants Sales (Kg) by Company (2015-2020) Table 70. India Vaccine Adjuvants Sales Market Share by Company (2015-2020) Table 71. India Vaccine Adjuvants Sales (Kg) by Type (2015-2020) Table 72. India Vaccine Adjuvants Sales Market Share by Type (2015-2020) Table 73. India Vaccine Adjuvants Sales (Kg) by Application (2015-2020) Table 74. India Vaccine Adjuvants Sales Market Share by Application (2015-2020) Table 75. SEPPIC Corporation Information Table 76. SEPPIC Description and Business Overview Table 77. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 78. SEPPIC Vaccine Adjuvants Product Table 79. SEPPIC Recent Development Table 80. SDA BIO Corporation Information Table 81. SDA BIO Description and Business Overview Table 82. SDA BIO Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 83. SDA BIO Vaccine Adjuvants Product Table 84. SDA BIO Recent Development Table 85. Croda International Plc Corporation Information Table 86. Croda International Plc Description and Business Overview Table 87. Croda International Plc Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 88. Croda International Plc Vaccine Adjuvants Product Table 89. Croda International Plc Recent Development Table 90. SPI Pharma Corporation Information Table 91. SPI Pharma Description and Business Overview Table 92. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 93. SPI Pharma Vaccine Adjuvants Product Table 94. SPI Pharma Recent Development Table 95. Phibro Animal Health Corporation Corporation Information Table 96. Phibro Animal Health Corporation Description and Business Overview Table 97. Phibro Animal Health Corporation Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 98. Phibro Animal Health Corporation Vaccine Adjuvants Product Table 99. Phibro Animal Health Corporation Recent Development Table 100. Tj Kaiwei Corporation Information Table 101. Tj Kaiwei Description and Business Overview Table 102. Tj Kaiwei Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 103. Tj Kaiwei Vaccine Adjuvants Product Table 104. Tj Kaiwei Recent Development Table 105. Novavax Corporation Information Table 106. Novavax Description and Business Overview Table 107. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 108. Novavax Vaccine Adjuvants Product Table 109. Novavax Recent Development Table 110. Zhuoyue Corporation Information Table 111. Zhuoyue Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 112. Zhuoyue Description and Business Overview Table 113. Zhuoyue Vaccine Adjuvants Product Table 114. Zhuoyue Recent Development Table 115. Aphios Corporation Information Table 116. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 117. Aphios Description and Business Overview Table 118. Aphios Vaccine Adjuvants Product Table 119. Aphios Recent Development Table 120. GSK Corporation Information Table 121. GSK Description and Business Overview Table 122. GSK Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 123. GSK Vaccine Adjuvants Product Table 124. GSK Recent Development Table 125. CSL Limited Corporation Information Table 126. CSL Limited Description and Business Overview Table 127. CSL Limited Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 128. CSL Limited Vaccine Adjuvants Product Table 129. CSL Limited Recent Development Table 130. Brenntag Biosector Corporation Information Table 131. Brenntag Biosector Description and Business Overview Table 132. Brenntag Biosector Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 133. Brenntag Biosector Vaccine Adjuvants Product Table 134. Brenntag Biosector Recent Development Table 135. SEPPIC Corporation Information Table 136. SEPPIC Description and Business Overview Table 137. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 138. SEPPIC Vaccine Adjuvants Product Table 139. SEPPIC Recent Development Table 140. SPI Pharma Corporation Information Table 141. SPI Pharma Description and Business Overview Table 142. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 143. SPI Pharma Vaccine Adjuvants Product Table 144. SPI Pharma Recent Development Table 145. Novavax Corporation Information Table 146. Novavax Description and Business Overview Table 147. Novavax Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 148. Novavax Vaccine Adjuvants Product Table 149. Novavax Recent Development Table 150. Avanti Polar Lipids Corporation Information Table 151. Avanti Polar Lipids Description and Business Overview Table 152. Avanti Polar Lipids Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 153. Avanti Polar Lipids Vaccine Adjuvants Product Table 154. Avanti Polar Lipids Recent Development Table 155. Aphios Corporation Information Table 156. Aphios Description and Business Overview Table 157. Aphios Vaccine Adjuvants Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 158. Aphios Vaccine Adjuvants Product Table 159. Aphios Recent Development Table 160. Production Base and Market Concentration Rate of Raw Material Table 161. Key Suppliers of Raw Materials Table 162. Vaccine Adjuvants Distributors List Table 163. Vaccine Adjuvants Customers List Table 164. Vaccine Adjuvants Market Key Trends Table 165. Vaccine Adjuvants Key Opportunities and Drivers Table 166. Vaccine Adjuvants Market Challenges Table 167. Research Programs/Design for This Report Table 168. Key Data Information from Secondary Sources Table 169. Key Data Information from Primary Sources List of Figures Figure 1. Vaccine Adjuvants Product Picture Figure 2. Global Vaccine Adjuvants Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Vaccine Adjuvants Market Share by Application in 2020 & 2026 Figure 6. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Examples Figure 7. Human Vaccine Adjuvants (Research Applications, Commercial Applications) Examples Figure 8. Global Vaccine Adjuvants Sales (Kg) Growth Rate (2015-2026) Figure 9. Global Vaccine Adjuvants Revenue (US$ Million) Growth Rate (2015-2026) Figure 10. Global Vaccine Adjuvants Price Trends Growth Rate (2015-2026) (USD/Kg) Figure 11. Global Vaccine Adjuvants Revenue Market Share by Region: 2015 VS 2020 Figure 12. Global Vaccine Adjuvants Revenue Market Share by Region: 2021 VS 2026 Figure 13. United States Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026) Figure 14. United States Vaccine Adjuvants Sales (Kg) Growth Rate (2015-2026) Figure 15. Europe Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026) Figure 16. Europe Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026) Figure 17. China Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026) Figure 18. China Vaccine Adjuvants Sales (Million USD) and Growth Rate (2015-2026) Figure 19. Japan Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026) Figure 20. Japan Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026) Figure 21. Southeast Asia Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026) Figure 23. India Vaccine Adjuvants Revenue (Million USD) Growth Rate (2015-2026) Figure 24. India Vaccine Adjuvants Sales (Million USD) Growth Rate (2015-2026) Figure 25. Global 5 Largest Vaccine Adjuvants Players Market Share by Revenue in Vaccine Adjuvants 2015 & 2019 Figure 26. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 27. Global Vaccine Adjuvants Revenue Share by Type (2015-2020) Figure 28. Global Vaccine Adjuvants Revenue Growth Rate by Type in 2015 & 2019 Figure 29. Global Vaccine Adjuvants Revenue Share by Application (2015-2020) Figure 30. Global Vaccine Adjuvants Revenue Growth Rate by Application in 2015 & 2019 Figure 31. United States Vaccine Adjuvants Sales Market Share by Type in 2019 Figure 32. United States Vaccine Adjuvants Sales Market Share by Type in 2019 Figure 33. Europe Vaccine Adjuvants Sales Market Share by Company in 2019 Figure 34. Europe Vaccine Adjuvants Sales Market Share by Type in 2019 Figure 35. Europe Vaccine Adjuvants Sales Market Share by Application in 2019 Figure 36. China Vaccine Adjuvants Sales Market Share by Company in 2019 Figure 37. China Vaccine Adjuvants Sales Market Share by Type in 2019 Figure 38. China Vaccine Adjuvants Sales Market Share by Application in 2019 Figure 39. Japan Vaccine Adjuvants Sales Market Share by Company in 2019 Figure 40. Japan Vaccine Adjuvants Sales Market Share by Type in 2019 Figure 41. Japan Vaccine Adjuvants Sales Market Share by Application in 2019 Figure 42. Southeast Asia Vaccine Adjuvants Sales Market Share by Company in 2019 Figure 43. Southeast Asia Vaccine Adjuvants Sales Market Share by Type in 2019 Figure 44. Southeast Asia Vaccine Adjuvants Sales Market Share by Application in 2019 Figure 45. India Vaccine Adjuvants Sales Market Share by Company in 2019 Figure 46. India Vaccine Adjuvants Sales Market Share by Type in 2019 Figure 47. India Vaccine Adjuvants Sales Market Share by Application in 2019 Figure 48. Key Raw Materials Price Trend Figure 49. Manufacturing Cost Structure of Vaccine Adjuvants Figure 50. Manufacturing Process Analysis of Vaccine Adjuvants Figure 51. Vaccine Adjuvants Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Porter's Five Forces Analysis Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

SEPPIC SDA BIO Croda International Plc SPI Pharma Phibro Animal Health Corporation Tj Kaiwei Novavax Zhuoyue Aphios GSK CSL Limited Brenntag Biosector SEPPIC SPI Pharma Novavax Avanti Polar Lipids Aphios